Regular walking during recovery may reduce cancer-related fatigue and improve long-term well-being for patients with ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.comNews Commentary – ...

SAN FRANCISCO -- Including encorafenib (Braftovi) and cetuximab (Erbitux) in the first-line treatment of BRAF V600E-mutated ...

Colorectal cancer — which includes cancer of the colon and of the rectum — is considered early onset when diagnosed in people under the age of 50. While the majority of diagnoses are still among ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer, reported a new study published in Cancer Investigation. GLP-1 receptor agonists were originally ...

Colon cancer patients could live longer if they take GLP-1 drugs like Ozempic and Wegovy, a new study suggests. Researchers at UC San Diego studied more than 6,800 patients who were taking one of ...

After an increase in colorectal cancer among patients younger than 50, U.S. guidelines started recommending that screening begin at age 45 for average-risk adults. This study showed that ...

A person walks past blue flags placed on the National Mall near the Capitol as part of an effort to advocate for funding and research into fighting colorectal cancer, Wednesday, March 12, 2025, in ...

A common vaccine could help to fight cancer, a new study suggests. For cancer patients undergoing immunotherapy, researchers found that receiving the mRNA COVID-19 vaccine within about 100 days of ...

Colorectal cancer is the third most common cancer worldwide. It is estimated that there are over 1.5 million diagnoses a year. Specifically, in the United States, there is estimated to have over ...

Cancer patients are more likely to survive if they live in a state that expanded its Medicaid program under the Affordable Care Act, new research shows. Patients were more likely to have higher ...